ConductScience.org, home

Paper37511795

Early MRI Predictors of Relapse in Primary Central Nervous System Lymphoma Treated with MATRix Immunochemotherapy.

Cornell I and 9 others. J Pers Med, 2023. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Early MRI Predictors of Relapse in Primary Central Nervous System Lymphoma Treated with MATRix Immunochemotherapy. Papers, record 37511795. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37511795

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Early MRI Predictors of Relapse in Primary Central Nervous System Lymphoma Treated with MATRix Immunochemotherapy.
PubMed
Journal
J Pers Med
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.39
iCite
Revised in PubMed
2023-08-01
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cornell IIsabel
2Al Busaidi AAyisha
3Wastling SStephen
4Anjari MMustafa
5Cwynarski KKate
6Fox CPChristopher P
7Martinez-Calle NNicolas
8Poynton EEdward
9Maynard JJohn
10Thust SCSteffi C

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132662130Primary Central Nervous System Lymphoma: Clinical Evaluation of Automated Segmentation on Multiparametric MRI Using Deep Learning.J Magn Reson Imaging2021https://conductscience.org/library/papers/32662130PubMed
233615224Extent of radiological response does not reflect survival in primary central nervous system lymphoma.Neurooncol Adv2021https://conductscience.org/library/papers/33615224PubMed
315955902Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.J Clin Oncol2005https://conductscience.org/library/papers/15955902PubMed
427341986
Value of pretherapeutic DWI in evaluating prognosis and therapeutic effect in immunocompetent patients with primary central nervous system lymphoma given high-dose methotrexate-based chemotherapy: ADC-based assessment.
Clin Radiol2016https://conductscience.org/library/papers/27341986PubMed
533560416Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG).Neuro Oncol2021https://conductscience.org/library/papers/33560416PubMed
625794073Histogram analysis of apparent diffusion coefficient maps for differentiating primary CNS lymphomas from tumefactive demyelinating lesions.AJR Am J Roentgenol2015https://conductscience.org/library/papers/25794073PubMed
719729544Diffusion-weighted MR imaging derived apparent diffusion coefficient is predictive of clinical outcome in primary central nervous system lymphoma.AJNR Am J Neuroradiol2010https://conductscience.org/library/papers/19729544PubMed
811121466Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors.J Natl Cancer Inst2000https://conductscience.org/library/papers/11121466PubMed
925802212Multi-centre reproducibility of diffusion MRI parameters for clinical sequences in the brain.NMR Biomed2015https://conductscience.org/library/papers/25802212PubMed
1031597366Whole Tumor Histogram Analysis Using DW MRI in Primary Central Nervous System Lymphoma Correlates with Tumor Biomarkers and Outcome.Cancers (Basel)2019https://conductscience.org/library/papers/31597366PubMed
1134185076The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.Neuro Oncol2021https://conductscience.org/library/papers/34185076PubMed
1228108885Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials.Neurotherapeutics2017https://conductscience.org/library/papers/28108885PubMed
1312091680Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics.Radiology2002https://conductscience.org/library/papers/12091680PubMed
1436978676Radiomics-Based Machine Learning Model for Predicting Overall and Progression-Free Survival in Rare Cancer: A Case Study for Primary CNS Lymphoma Patients.Bioengineering (Basel)2023https://conductscience.org/library/papers/36978676PubMed
1530888569Primary central nervous system lymphoma in patients with and without HIV infection: a multicenter study and comparison with U.S national data.Cancer Causes Control2019https://conductscience.org/library/papers/30888569PubMed
1628427529Primary central nervous system lymphoma.Crit Rev Oncol Hematol2017https://conductscience.org/library/papers/28427529PubMed
1724814181Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion-, perfusion-, and susceptibility-weighted MR imaging.Radiology2014https://conductscience.org/library/papers/24814181PubMed
1831997308
Induction therapy with the MATRix regimen in patients with newly diagnosed primary diffuse large B-cell lymphoma of the central nervous system - an international study of feasibility and efficacy in routine clinical practice.
Br J Haematol2020https://conductscience.org/library/papers/31997308PubMed
1933692222Texture Analysis in Brain Tumor MR Imaging.Magn Reson Med Sci2022https://conductscience.org/library/papers/33692222PubMed
2022228634Immunochemotherapy with intensive consolidation for primary CNS lymphoma: a pilot study and prognostic assessment by diffusion-weighted MRI.Clin Cancer Res2012https://conductscience.org/library/papers/22228634PubMed

See all 40 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42428147MRI biomarkers of primary CNS lymphoma outcome after MATRix: real world performance.Front Oncol2026https://conductscience.org/library/papers/42428147PubMed
42394762MRI Predictors of Outcome in Primary Central Nervous System Lymphoma Patients Before and After Autologous Stem Cell Transplant.EJHaem2026https://conductscience.org/library/papers/42394762PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37511795

GET https://conductscience.org/api/papers/v1/37511795/references?page=2